| Literature DB >> 33884123 |
Bijoyaa Mohapatra1, Nachiketa Rout2.
Abstract
OBJECTIVE: To assess and describe the involvement of all speech subsystems, including respiration, phonation, articulation, resonance, and prosody, in an individual with cervical spinal cord injury.Entities:
Keywords: dysarthria; hoarse voice; speech intelligibility; spinal cord injury
Year: 2019 PMID: 33884123 PMCID: PMC8008712 DOI: 10.2340/20030711-1000022
Source DB: PubMed Journal: J Rehabil Med Clin Commun ISSN: 2003-0711
Assessment of speech subsystems
| Assessment | Area/task | Results | Remarks | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| French-ay Dysarthria Assessment-2 (FDA-2) | Reflexes (for cough, swallow, drool) | Rating - 6 (an equivalent of “b” on the FDA scale) | Very occasional difficulty with choking; Slight drooling with increased pauses when taking liquids | ||||||||||||||||||||||
| Respiration (at rest and during speech) | Rating - 2 (an equivalent of “d” on the FDA scale) | Indicative of little control over rate of inspiration or expiration; short of breath | Shallow breath and few words per breath cycle was managed; several breath cycles were taken to complete a speech narration. Indicative of occasional breaks in fluency due to poor respiratory control | Laryngeal (time, pitch, volume and during speech) | Rating - 4 (an equivalent of “c”’ on the FDA scale) | Difficulty maintaining clear phonation (sustains “ah” for 5-6 $, noticeably husky); uneven progression in volume during | Pitch and Volume - 2 (an equivalent of “d” on the FDA scale) | production of whisper and gradual transition to loud voice; greater difficulty in control of pitch and presence of pitch breaks. During speech, intonation was markedly impaired | Lips (at rest, spread, seal, alternate, and during speech condition) | Rating - 6 in all conditions (an equivalent of “b” on the FDA scale) | Slight asymmetry and air leakage, and occasional omissions due to lip weakness; Minimal deviations in arhythmicity of production of /o/ and /e/ that require alternate lip positions | Palate (during fluid intake, maintenance of vocalizations, and speech) | Rating - 6 in all conditions (an equivalent of “b” on the FDA scale) | Occasional nasal emissions were observed at the bridge of nose during speech; Reported occasional difficulty during coughing while taking fluids; During vocalization, slightly asymmetrical movement of the palate was observed | Tongue (at rest, protrusion, elevation, lateral and alternate movements, during speech) | Rating - 6 (an equivalent of “b” on the FDA scale) | Minimal deviations, slow protrusions, elevation and lateral movements were observed; | Speech - 5 (an equivalent between “b” and “c” on the FDA scale) | Slight incoordination during production of “ka la” and presence of mispronunciations and laboured speech | Intelligibility (for words and sentences) | Rating - 6 (an equivalent of “b” on the FDA scale) | At least 10 words were correctly interpreted by the evaluator, but care was be taken in listing and interpreting the ones that were difficult to comprehend | |||
| Cranial nerve examination | V, VII, XII | No observable deficits | |||||||||||||||||||||||
| IX | Mild difficulty with swallowing | ||||||||||||||||||||||||
| X | Loss of gag reflex | Laryngoscope examination revealed a phonatory gap indicative of vagus nerve number X denervation | |||||||||||||||||||||||
| XI | Restricted movement of shoulders and head turns | Shoulder droop indicative of spinal accessory nerve number XI denervation | |||||||||||||||||||||||
| Phonation | Phonation duration /a/ before initiation of any speech | 6 $ (mean of 3 readings) | Phonation duration was reduced in comparison with control group (18 $) | ||||||||||||||||||||||
| Phonation duration after 20 min continuous speech | 3 $ | ||||||||||||||||||||||||
| Phonation duration after 20 min vocal rest | 5 $ | ||||||||||||||||||||||||
| Articulation | 20 min continuous speech and reading aloud | Mild sibilant distortions; internalized /s/ at times | Distortions apparent along with decreased loudness and increased hoarseness | ||||||||||||||||||||||
| Syllable sequential diadchokinetic rates (DDK) /p t k/ | 6 syllables per $ (mean of 3 readings) | DDK was slightly reduced in comparison with control group (6.55 syllables per $) | |||||||||||||||||||||||
| Voice analysis Instrumental (Doctor Speech) | Voice analysis for sustained phonation /a/ for 5 $ | Average Co (Hz) - 131.90 | Reduced voice characteristics in comparison with data from control subjects: | ||||||||||||||||||||||
| Vocal quality ratings | Hoarse - severe | Voice quality was perceived to be reduced than healthy controls | |||||||||||||||||||||||
| Voice analysis Perceptual (Buffalo III voice screening profile) | Hoarse - moderate to severe | Moderate to severe breathy voice quality with severely reduced loudness (Mean of ratings from 3 Alps) | |||||||||||||||||||||||
| Nosometry (Gasometer Reading on “zoo” passage II) | No nasal consonants | Inconsistent nasal airflow was detected on a mirror held at the nares during repetition of non-nasal sounds and phrases | |||||||||||||||||||||||
| Intelligibility (AssIDSS) | Reading text and Continuous speech activity | Intelligible Reading Rate - 82 BPM (140 BPM for control group) | CER showed reduction in intelligibility, determined by BPM | ||||||||||||||||||||||
| Intelligible Speaking rate - 62 BPM (110 WPM for control group) | |||||||||||||||||||||||||
| CER~0.56 | |||||||||||||||||||||||||
| Single word intelligibility on Articulation test - 96% | |||||||||||||||||||||||||
| IWPM for sentences during connected speech - 96%; during reading - 97% |
FDA: French-ay Dysarthria Assessment; Alps: speech-language pathologists; assess: Assessment of Intelligibility of Dysarthric Speech; WPM: words per min; IWPM: intelligible of words per min; ACER: communication efficiency ratio; Co: fundamental frequency; BSD: standard deviation, NINE: normalized noise energy; SNR: signal to noise ratio.